1. Relationship of IL-2, IL-2R (CD25+), soluble IL-2R and IL-4 with disease activity in SLE patients;Cuadrado, M.J.; Marubayashi, M.; Ortega, C.; Fernandez-Arcas, N.; Garcia-Cozar, F.; Pena, J.;Lupus,1993
2. Decreased production of interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus;Alcocer-Varela, J.; Alarcon-Segovia, D.;J Clin Invest,1982
3. The interleukin-2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells;Huang, Y.P.; Miescher, P.A.; Zubler, R.H.;J Immunol,1986
4. Soluble IL-2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with SLE;Razziudin, S.; Al Janadi, M.A.; Wabell, A.A.,1991
5. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus. Clin Exp Immunol;Ter-Borg, E.J.; Horst, G.; Limburg, P.C.; Kallenberg, C.G.,1990